CClinicalTrials.gg
CompletedNCT05019612ROXWELLUpdated Jul 17, 2026

The Role of Expectations on Complaints and Well-being After Endometriosis Surgery in Women

An observational study in Endometriosis, Expectations and Laparoscopy, sponsored by Helmut Schmidt University. Completed at 1 site in Germany. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Helmut Schmidt University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
395
Ages
18 Years and older
Sex
Female
01

Study summary

Endometriosis is a prevalent disease in women of procreative age. Most endometriosis patients are affected in their daily life by complaints such as chronic pelvic pain, dysmenorrhoea, infertility, or pain during sexual intercourse. Yet, its etiology is poorly understood. Although laparoscopy is well known as the gold standard for treating endometriosis, 20-30% of treated women still show persistent complaints following successful laparoscopy.

It has been widely recognized that expectations profoundly affect treatment courses and outcomes in many different health conditions. Additionally, evidence suggests that optimizing preoperative expectations can improve post-operative outcomes such as disability and return to work.

The objective of this study is to investigate whether expectations also affect treatment course and outcome in women after endometriosis surgery. For this purpose, the investigators conduct a mixed-method observational cohort study to gather data on psychological factors, particularly treatment and symptom-related expectations, as well as complaints and well-being of patients after surgery. A sample of N = 300 women will be asked pre- and postoperatively to evaluate these psychological factors and indicators of treatment course and outcome. Overall, the study will last 12 months, including one assessment preoperatively (baseline), seven monthly assessments postoperatively, and a follow-up assessment 12 months after endometriosis surgery.

The study aims to determine potential interactions between aforementioned psychological factors, their influence on the postoperative health, and the long- and short-term symptom course of patients with endometriosis. The study results will provide a better understanding of the symptom- and treatment course in women with endometriosis and subsequently supply clinical approaches to optimize treatment of endometriosis.

Read the detailed description

Rationale:

According to the evidence-based S2-treatment guidelines for endometriosis, laparoscopy is the method of choice to remove endometriosis and is associated with considerable symptom improvement. However, 20-30% of treated women (so-called non-responders) still report symptoms and impairments after surgery; this is not explainable by laparoscopy itself or a recurrence of endometriosis. Relevant psychosocial predictors are higher age and pain catastrophization, though both only explain a small amount of persistent symptoms and impairments. This indicates a potential role of other psychological factors influencing treatment outcome, such as expectations.

Evidence for this assumption is provided by placebo-response rates of 30% in women who had a sham endometriosis surgery and even reported symptom improvements after diagnostic (sham) laparoscopy. Concerning other gynaecological settings, research already implies that expectations have a remarkable impact on treatment outcome and quality of life in women with breast cancer. Likewise, the role of expectations could be important for the optimal treatment of endometriosis.

However, there is no study examining the role of expectations on treatment outcomes in women with endometriosis to date. Therefore, this study investigates the influence of expectations and other psychological factors on complaints and well-being of patients after surgery in women with endometriosis.

Method:

In the proposed study, a sample of 300 women will report pre- and postoperatively about their treatment and symptom expectations, health condition, and other psychological factors that may influence treatment course and outcome after endometriosis surgery. Overall, this monitoring will last 12 months, including one assessment preoperatively (baseline), seven monthly assessments postoperatively, and a follow-up assessment 12 months after endometriosis surgery. All assessments will be conducted online.

Within the scope of an embedded qualitative study, a partial sample of 20 to 30 women will be interviewed preoperatively and postoperatively about their treatment and symptom expectations, fears, and concerns regarding the laparoscopy.

Above that, a second partial sample of 20 women will report on seven consecutive days about their current health condition, and treatment and symptom expectations in their everyday life using ambulatory assessment (smartphone-based measurements).

Objectives:

Firstly, the investigators are interested in the treatment course and outcome and its possible changes over a period of six months after endometriosis surgery. Secondly, the role of pre- and post-operative expectations for treatment course and outcome for women with endometriosis should be determined. Besides expectations, the investigators will finally examine further potential psychological and social predictors for treatment outcome, e.g., prior treatment experiences, state anxiety, depression, pain catastrophization and demographics, in order to optimize endometriosis therapy.

Regarding the embedded qualitative study, the investigators explore and categorize the mentioned treatment- and symptom-related expectations concerning endometriosis surgery (laparoscopy) and psychological factors that potentially improve or harm women's treatment outcome and health condition. The ambulatory assessment offers a monitoring of patients' symptom course in their daily lives and the determination of potential modulators

02

Conditions studied

  • Endometriosis
  • Expectations
  • Laparoscopy

Browse trials for

Keywords

  • cohort study
  • endometriosis
  • surgery
  • laparoscopy
  • expectation
  • nocebo
  • placebo
03

In context

Endometriosis

901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.

This study's enrollment of 395 is above the median of 128 across 344 observational studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

This is the only study on the registry with Helmut Schmidt University as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Women will be selected who are treated in the Frauenklinik an der Elbe.

Inclusion criteria

  1. Adult women (18+)
  2. Endometriosis related symptoms and complaints
  3. Clinical indication for surgery/laparoscopy
  4. Clinically diagnosed endometriosis (postoperatively)
  5. Informed consent
  6. Sufficient knowledge of the German language

Exclusion criteria

Exclusion Criteria:

  1. Incomplete excision of endometriosis
  2. Malignant biopsy result (postoperatively)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
395 participants (actual)
Patient registry
No

Groups and cohorts

  • single-group/one cohort

    Women with endometriosis, having the clinical indication for laparoscopic endometriosis excision

    Procedure: Laparoscopy: A minimal invasive surgery

Interventions

  • ProcedureLaparoscopy: A minimal invasive surgery

    A low-risk minimal invasive surgery performed in the pelvis using small incisions. With the aid of a laparoscope, the operator views the affected area in real-time. Beyond that, the camera sends images to a video monitor. The operator obtains endometriosis and biopsy samples with small surgical instruments. Before laparoscopy, individuals are provided with a general anaesthetic to relax muscles and prevent pain during surgery.

06

What researchers measure

Primary outcomes

  1. Course of Endometriosis related Pain Disability - Pain Disability Index (PDI-D)

    The PDI-D assesses the self-reported disability by endometriosis symptoms using a numeric rating scale with eleven response options (0-10). The overall total score will be calculated by gathering all seven items. The course of endometriosis related pain disability over the measurement points will be analysed as the primary outcome.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow-up 12 months after surgery

Secondary outcomes

  1. Severity of endometriosis-related complaints - self-conducted rating scale (NRScomplaints)

    The NRScomplaints Questionnaire assesses the self-reported severity of the five most prevalent endometriosis symptoms (dysmenorrhoea, pelvic pain, dyspareunia, dyschezia, dysuria) by a numeric rating scale with eleven response options (0-10). The overall total score will be examined.

    Time frame: at baseline, seven times consecutive with an interval of 4 weeks, follow up 12 months after surgery

  2. Mental well-being - Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS)

    The SWEMWBS assesses the self-reported mental well-being using seven statements about thoughts and feelings with five response (1=never to 5=always) options. The total score ranges from 7 to 35, higher sum scores reflect a higher level of mental well-being.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow up 12 months after surgery

  3. Health related quality of life - Endometriosis Health Profile (EHP-5)

    The EHP-5 measures the wide range of effects that endometriosis can have on women's lives covering five items with five response options (0=never to 4=always). A higher sum score reflects a higher level of self-reported impairment.

    Time frame: at baseline, seven times consecutive with an interval of 4 weeks, follow up 12 months after surgery

  4. Current Treatment effects - 'Generic rating scale for treatment effects' (GEEE_ACT)

    The GEEE\_ACT assesses the self-reported current treatment effects on endometriosis related complaints using three numeric rating scales with eleven response options (0-10). The total sum score will be examined.

    Time frame: Continuous measurement postoperatively, seven times with an interval of four weeks

Other outcomes

  1. Impairments by somatic symptoms - Patient Health Questionnaire (PHQ-15)

    The PHQ-15 assesses patients' self-reported impairment and consists of 15 physical symptoms with eleven response options (0-10). The total score ranges from 0 to 30, with higher scores indicating more impairment.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow up 12 months after surgery

  2. Treatment expectations - Treatment Expectation Questionnaire (TEX-Q)

    The TEX-Q measures patients' self-reported treatment expectations and consists of 15 items with eleven response options (0-10). The total score ranges from 0 to 150 with higher scores implying more positive treatment expectations.

    Time frame: at baseline

  3. Expected Endometriosis Pain Disability - Pain Disability Index, adapted (PDI-expect)

    The PDI-expect assesses the expected disability by endometriosis symptoms using a numeric rating scale with eleven response options (0-10). The overall total score will be examined by gathering all seven items.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow up 12 months after surgery

  4. Symptom expectation - self-conducted rating scale (NRS_Symptomexpect)

    The NRSSymptomexpect Questionnaire assesses the expected symptom severity of the five most prevalent endometriosis symptoms (dysmenorrhoea, pelvic pain, dyspareunia, dyschezia, dysuria) using a numeric rating scale with eleven response options (0-10). The overall total score will be examined.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow up 12 months after surgery

  5. Pre-experiences with endometriosis treatment/surgery - Generic rating scale for previous treatment experiences (GEEE_PRE)

    The GEEE\_PRE is a self-reported measure to assess previous experiences with endometriosis treatment/surgery. If experience with endometriosis surgery is indicated, three items are presented to rate the experiences on a numeric analogue scale (0-10). The total sum score will be examined.

    Time frame: at baseline

  6. Treatment expectations - Generic rating scale for treatment expectations (GEEEEXP)

    The GEEE\_EXP assesses treatment expectations related to endometriosis surgery using three numeric rating scales with eleven response options (0-10). The total sum score will be examined.

    Time frame: at baseline, seven times consecutive with an interval of four weeks, follow up 12 months after surgery

  7. Depressive and anxiety - Patient Health Questionnaire (PHQ-4)

    The PHQ-4 comprises four items, inquiring the degree to which an individual experiences anxiety or a depressed mood through a four-level likert scale (0-3). The overall total score ranges from 0 to 12. A higher sum score indicates a higher level of state anxiety and depression.

    Time frame: at baseline

  8. Pain Catastrophization - subscale of the Coping- strategy questionnaire (CSQ-D)

    The Pain catastrophization subscale assesses pain catastrophization, compromising six items with seven response options (0=never do that to 6=always do that). A total score will be examined. A higher sum score indicates a higher level of pain catastrophization.

    Time frame: at baseline

07

Study locations

1 site
  • Helmut Schmidt University
    Hamburg, Germany
08

References and documents

Publications

  • von Blanckenburg P, Schuricht F, Albert US, Rief W, Nestoriuc Y. Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial. BMC Cancer. 2013 Sep 18;13:426. doi: 10.1186/1471-2407-13-426. PubMed 24047450 ↗
  • Heisig SR, Shedden-Mora MC, von Blanckenburg P, Schuricht F, Rief W, Albert US, Nestoriuc Y. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence. Psychooncology. 2015 Feb;24(2):130-7. doi: 10.1002/pon.3611. Epub 2014 Jun 21. PubMed 24953538 ↗
  • Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, Rief W. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol. 2016 Oct;27(10):1909-15. doi: 10.1093/annonc/mdw266. Epub 2016 Aug 22. PubMed 27551051 ↗
  • Pan Y, Kinitz T, Stapic M, Nestoriuc Y. Minimizing Drug Adverse Events by Informing About the Nocebo Effect-An Experimental Study. Front Psychiatry. 2019 Jul 25;10:504. doi: 10.3389/fpsyt.2019.00504. eCollection 2019. PubMed 31427995 ↗
  • Quidde J, Pan Y, Salm M, Hendi A, Nilsson S, Oechsle K, Stein A, Nestoriuc Y. Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients. BMC Cancer. 2018 Sep 24;18(1):916. doi: 10.1186/s12885-018-4814-7. PubMed 30249191 ↗
  • Shedden-Mora MC, Pan Y, Heisig SR, von Blanckenburg P, Rief W, Witzel I, Albert US, Nestoriuc Y. Optimizing Expectations About Endocrine Treatment for Breast Cancer: Results of the Randomized Controlled PSY-BREAST Trial. Clin Psychol Eur. 2020 Mar 31;2(1):e2695. doi: 10.32872/cpe.v2i1.2695. eCollection 2020 Mar. PubMed 36397978 ↗
  • Nestoriuc Y, Kleine-Borgmann J. [Appearances are not deceptive: clinical evidence and new research approaches to open-label placebo]. Nervenarzt. 2020 Aug;91(8):708-713. doi: 10.1007/s00115-020-00953-6. German. PubMed 32691079 ↗
  • Meyrose AK, Basedow LA, Hirsing N, Buchweitz O, Rief W, Nestoriuc Y. Assessment of treatment expectations in people with suspected endometriosis: A psychometric analysis. F1000Res. 2024 Sep 9;13:174. doi: 10.12688/f1000research.145377.2. eCollection 2024. PubMed 39328391 ↗
  • Hirsing N, Meyrose AK, Buchweitz O, Nestoriuc Y. Do expectations determine postoperative disability in women with endometriosis? Study protocol for a clinical mixed-methods observational cohort study. BMJ Open. 2023 Jan 4;13(1):e067497. doi: 10.1136/bmjopen-2022-067497. PubMed 36599637 ↗

Study documents

  • Statistical analysis plan · Jul 16, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in published articles will be shared after deidentification via a repository. A study protocol is available. Audio records will be deleted, transcripts are available following publications upon reasonable request.

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05019612
Lead sponsor
Helmut Schmidt University
Collaborators
Frauenklinik an der Elbe
Responsible party
Dr. Yvonne Nestoriuc (Prof., Helmut Schmidt University) — Principal investigator
First posted
Aug 25, 2021
Start date
Aug 25, 2021
Primary completion
Jun 20, 2024
Completion
Jun 20, 2024
Last update
Jul 17, 2026

Study contacts

Yvonne Nestoriuc, Prof. Dr.
principal investigator · Helmut Schmidt University/ University of the Federal Armed Forces Hamburg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion